Literature DB >> 8828468

Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells.

S A Beak1, C J Small, I Ilovaiskaia, J D Hurley, M A Ghatei, S R Bloom, D M Smith.   

Abstract

We have demonstrated specific binding sites for [125I]glucagon-like peptide 1 (GLP-1) on membranes from the rodent thyrotrope cell line, alpha-TSH. Specific [125I]GLP-1 binding was saturable and time dependent. Equilibrium saturation binding analysis was consistent with the presence of a single class of binding site (binding capacity, 85 +/- 7 fmol/mg protein) with a dissociation constant (Kd) of 28 +/- 13 pM. The specific GLP-1 receptor agonists, exendin-4 and exendin-3, and the antagonist, exendin-(9-39), bound to the receptor sites with high affinity (Ki = 190 +/- 70 pM; 130 +/- 50 and 1200 +/- 470 pM, respectively). Chemical cross-linking of [125I]GLP-1-receptor complexes revealed a single band of 64,300 +/- 100 Mr in alpha-TSH membranes. In addition, specific PCR studies demonstrated the presence of GLP-1 receptor messenger RNA. Binding of the peptide to alpha-TSH cell membranes resulted in increased intracellular cAMP concentrations (10 nM GLP-1, 1010 +/- 83 pmol/10(6) cells.h; control, 175 +/- 60 pmol/10(6) cells.h; P < 0.002), indicating that the receptor is linked to stimulation of adenylyl cyclase. GLP-1-mediated increases in cAMP were inhibited by exendin-(9-39) in a dose-dependent manner. Furthermore, GLP-1 stimulates basal TSH release from dispersed anterior pituitary cells in a concentration-dependent manner (100 nM GLP-1, 63 +/- 3 fmol/10(6) cells.h; control, 35 +/- 1 fmol/10(6) cells.h; P < 0.0005), but had no effect on basal PRL, GH, or LH release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828468     DOI: 10.1210/endo.137.10.8828468

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity.

Authors:  H A Coppock; A A Owji; C Austin; P D Upton; M L Jackson; J V Gardiner; M A Ghatei; S R Bloom; D M Smith
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

2.  Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.

Authors:  S A Beak; M M Heath; C J Small; D G Morgan; M A Ghatei; A D Taylor; J C Buckingham; S R Bloom; D M Smith
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 3.  Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.

Authors:  E Blázquez; E Alvarez; M Navarro; I Roncero; F Rodríguez-Fonseca; J A Chowen; J A Zueco
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 4.  Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.

Authors:  Wijnand J C van der Velden; Laura H Heitman; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

Review 5.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

Review 6.  Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides.

Authors:  Rania Abu-Hamdah; Atoosa Rabiee; Graydon S Meneilly; Richard P Shannon; Dana K Andersen; Dariush Elahi
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

7.  The Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume.

Authors:  Muhammed Erkam Sencar; Davut Sakiz; Murat Calapkulu; Sema Hepsen; Muhammed Kizilgul; Ilknur Unsal Ozturk; Bekir Ucan; Murat Bayram; Busra Betul Cagir; Safak Akin; Mustafa Ozbek; Erman Cakal
Journal:  Eur Thyroid J       Date:  2019-08-15

8.  GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats.

Authors:  Wijnand J C van der Velden; Florent X Smit; Charlotte B Christiansen; Thor C Møller; Gertrud M Hjortø; Olav Larsen; Sine P Schiellerup; Hans Bräuner-Osborne; Jens J Holst; Bolette Hartmann; Thomas M Frimurer; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-19

9.  Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice.

Authors:  R N Kulkarni; Z L Wang; R M Wang; J D Hurley; D M Smith; M A Ghatei; D J Withers; J V Gardiner; C J Bailey; S R Bloom
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

10.  Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis.

Authors:  B M McGowan; S A Stanley; J Donovan; E L Thompson; M Patterson; N M Semjonous; J V Gardiner; K G Murphy; M A Ghatei; S R Bloom
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.